Sign in

CIK 0001609809

  • Non-accelerated filer
  • Smaller reporting company

Seres Therapeutics, Inc.

Sign in to watch
Ticker
MCRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
274326290
Phone
+1 617-945-9626
Business address
200 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
Seres Therapeutics, Inc., Seres Health, Inc.
  1. 4 Planned sale CEO and President sold 8,552 shares at $1.35 ($11,545)
  2. 4 Planned sale Young Teresa L. sold 2,907 shares at $1.35 ($3,924)
  3. 4 Planned sale Chief Financial Officer sold 4,066 shares at $1.35 ($5,489)
  4. 4 Planned sale Chief Legal Officer and EVP sold 4,156 shares at $1.35 ($5,611)
  5. 4 Planned sale Ege David S. sold 4,066 shares at $1.35 ($5,489)
  6. 4 Planned sale von Moltke Lisa sold 4,232 shares at $1.35 ($5,713)
  7. 4 Planned sale Henn Matthew R. sold 3,886 shares at $1.35 ($5,246)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Open-market sale Ege David S. sold 7,038 shares at $5.19 ($36,527)
  17. 4 Grant or award Chief Financial Officer acquired 42,500 shares (grant or award)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 19 · 380 filings